Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway

Prostate

Volumn 42, Issue 3, 2000, Pages 239-242

  Lou, Wei ^a   Ni, Zuyao ^a   Dyer, Kevin ^a   Tweardy, David J ^a   Gao, Allen C ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

IL 6; Prostate cancer; Signaling pathway; STAT

Indexed keywords

ANDROGEN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE; STAT3 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; GROWTH REGULATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNAL TRANSDUCTION;

ANTIGENS, CD; CELL DIVISION; CYTOKINE RECEPTOR GP130; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0034651980     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G     Document Type: Article

References (18)

1. Hirano T. Interleukin 6. In: Thomson A, editor. The cytokine handbook. London: Academic Press; 1994. p 145-168.
2. Heinrich P, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/ STAT pathway. Biochem J 1998;334:297-314.
3. Schindler C, Darnell JE Jr. Transcriptional response to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64:621-651.
4. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 1996;15:3651-3658.
5. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607-610.
6. Okamoto M, Lee C, Oyasu R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 1997;57:141-146.
7. Siegsmund MJ, Yamazaki H, Pastan I. Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J Urol 1994;151:1396-1399.
8. Twillie DA, Eisenberger MA, Carducci MA, Hseih WS, Kim WY, Simons JW. Interleukin-6: a candidate mediator of human prostate cancer morbidity. Urology 1995;45:542-549.
9. Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT, Thompson TC. Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma. J Urol 1999;161:182-187.
10. Gao AC, Isaacs JT. Expression of homeobox gene-GBX2 in human prostatic cancer cells. Prostate 1996;29:395-398.
11. Gao AC, Lou W, Isaacs JT. Down regulation of homeobox gene GBX2 inhibits human prostate cancer clonogenic ability and tumorigenicity. Cancer Res 1998;58:1391-1394.
12. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990;9:1897-1906.
13. Gao AC, Lou W, Dong JT, Isaacs JT. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res 1997;57:846-849.
14. Grandis RJ, Zeng Q, Tweardy DJ. Retinoic acid normalized the increased gene transcription rate of TGF-α and EGFR in head and neck cancer. Nat Med 1996;2:237-240.
15. Gao AC, Lou W, Ichikawa T, Denmeade SR, Barrett JC, Isaacs JT. Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2. Prostate 1999;38:46-54.
16. Chung TDK, Yu J, Spiotto MT, Bartkowski M, Simons JW. Characterization of the role of IL-6 in the progression of prostate cancer. Prostate 1999;38:199-207.
17. kip1, a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochem Biophys Res Commun 1999;257:609-614.
18. Qiu Y, Ravi L, Kung HJ. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells. Nature 1998;393:83-85.